The Department of Justice spent a substantial amount of time and energy targeting healthcare fraud in 2023, according to a new 80-page report. Some of the year's biggest settlements involved cardiac surgery and cardiac imaging. 

Interventional cardiologists have been anticipating this news for quite some time. The device, the first of its kind, provides an alternative treatment option to repeat PCI or cardiac surgery for patients with coronary ISR.

CT calcium scoring provides valuable evaluations of intermediate-risk patients in addition to making good business sense for hospitals. Nauman Mushtaq, MD, an interventional cardiologist with Northwestern, shared his own experience with this technology. 

The news represents yet another big regulatory approval for PFA technology in 2024. Could FDA approval be next for Biosense Webster?

Startup vendor FIRE1 completed patient enrollment in its U.S. early feasibility study for a heart failure remote monitoring device that directly measures fluid volume inside the IVC.

The doctor appealed the hospital's decision in hopes of returning to work, but that appeal was ultimately denied. 

The self-expandable device was designed to treat “no-option” chest pain patients who see no long-term benefits from other interventions. 

Researchers explored the costs associated with CABG at more than 500 U.S. hospitals.